Despite 'losing money' in Russia, Roche commits to continuing its supply of essential medicines — report
Roche joined a handful of pharma companies in promising to continue its supply of essential medicines to Russia — but that promise has come at a cost, CEO Severin Schwan revealed.
In an interview with the Swiss newspaper Tages-Anzeiger, Schwan reaffirmed his commitment to providing life-saving cancer drugs to Russia, adding that there is an “international consensus that medicines are exempt from sanctions.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.